| Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review S Ferraro, F Braga, M Lanzoni, P Boracchi, EM Biganzoli, M Panteghini Journal of clinical pathology 66 (4), 273-281, 2013 | 239 | 2013 |
| Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis F Braga, S Pasqualetti, S Ferraro, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 54 (1), 7-15, 2016 | 197 | 2016 |
| Laboratory medicine in the new healthcare environment S Ferraro, F Braga, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 54 (4), 523-533, 2016 | 83 | 2016 |
| Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase F Braga, S Ferraro, R Mozzi, A Dolci, M Panteghini Clinical biochemistry 46 (1-2), 148-151, 2013 | 80 | 2013 |
| Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target S Ferraro, G Marano, EM Biganzoli, P Boracchi, AS Bongo Clinical chemistry and laboratory medicine 49 (9), 1397-1404, 2011 | 69 | 2011 |
| Human epididymis protein 4: factors of variation S Ferraro, D Schiumarini, M Panteghini Clinica Chimica Acta 438, 171-177, 2015 | 66 | 2015 |
| Revaluating serum ferritin as a marker of body iron stores in the traceability era S Ferraro, R Mozzi, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 50 (11), 1911-1916, 2012 | 63 | 2012 |
| The role of laboratory in ensuring appropriate test requests S Ferraro, M Panteghini Clinical biochemistry 50 (10-11), 555-561, 2017 | 59 | 2017 |
| Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin G Lippi, M Plebani, S Di Somma, V Monzani, M Tubaro, M Volpe, ... Clinical chemistry and laboratory medicine 50 (2), 243-253, 2012 | 58 | 2012 |
| Verification of harmonization of serum total and free prostate-specific antigen (PSA) measurements and implications for medical decisions S Ferraro, M Bussetti, S Rizzardi, F Braga, M Panteghini Clinical Chemistry 67 (3), 543-553, 2021 | 41 | 2021 |
| Serum α-fetoprotein in pediatric oncology: not a children’s tale S Ferraro, A Panzeri, F Braga, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 57 (6), 783-797, 2019 | 36 | 2019 |
| Measurement of serum neuron-specific enolase in neuroblastoma: Is there a clinical role? S Ferraro, F Braga, R Luksch, M Terenziani, S Caruso, M Panteghini Clinical Chemistry 66 (5), 667-675, 2020 | 35 | 2020 |
| The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer F Braga, S Ferraro, R Mozzi, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 52 (11), 1625-1631, 2014 | 35 | 2014 |
| Serum prostate-specific antigen testing for early detection of prostate cancer: managing the gap between clinical and laboratory practice S Ferraro, M Bussetti, M Panteghini Clinical Chemistry 67 (4), 602-609, 2021 | 33 | 2021 |
| Making new biomarkers a reality: the case of serum human epididymis protein 4 S Ferraro, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1284-1294, 2019 | 33 | 2019 |
| Definition of outcome-based prostate-specific antigen (PSA) thresholds for advanced prostate cancer risk prediction S Ferraro, M Bussetti, N Bassani, RS Rossi, GP Incarbone, F Bianchi, ... Cancers 13 (14), 3381, 2021 | 31* | 2021 |
| Verification of the harmonization of human epididymis protein 4 assays S Ferraro, S Borille, A Carnevale, E Frusciante, N Bassani, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 54 (10), 1635-1643, 2016 | 28 | 2016 |
| Human chorionic gonadotropin assays for testicular tumors: closing the gap between clinical and laboratory practice S Ferraro, C Trevisiol, M Gion, M Panteghini Clinical Chemistry 64 (2), 270-278, 2018 | 26 | 2018 |
| Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes S Ferraro, A Panzeri, M Panteghini Clinical Chemistry and Laboratory Medicine (CCLM) 55 (9), 1262-1275, 2017 | 26 | 2017 |
| Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up S Ferraro, C Robbiano, N Tosca, A Panzeri, AM Paganoni, M Panteghini Clinical Biochemistry 60, 84-90, 2018 | 25 | 2018 |
